Clinical Trials Logo

Current Every Day Smoker clinical trials

View clinical trials related to Current Every Day Smoker.

Filter by:

NCT ID: NCT04060446 Completed - Cigarette Smoker Clinical Trials

Effects of Filter Ventilation on Sensory Response, Smoking Topography, and Inhalation in Current Every Day Cigarette Smokers

Start date: June 6, 2019
Phase:
Study type: Observational

This trial examines the effects of filter ventilation on sensory response, smoking topography, and inhalation in current every day cigarette smokers. The physical design features of cigarettes directly impact their appeal by influencing cognitive and sensory perceptions. The introduction of a now common design feature, filter ventilation, has led to greater public harm than benefit because of the potential for greater toxicity while enhancing product appeal among smokers. Ventilated cigarettes dilute smoke, which promotes perceptions of ?smoothness? and therefore lower health risk, contributing to the overall appeal of these products. The purpose of this study is to assess whether removing ventilation from cigarette filters lowers cigarette product appeal among smokers.

NCT ID: NCT03865472 Recruiting - Cigarette Smoker Clinical Trials

rTMS in Promoting Smoking Cessation and Preventing Relapse in Current Smokers

Start date: November 10, 2018
Phase: N/A
Study type: Interventional

This trial studies best dose and how well repetitive transcranial magnetic stimulation (rTMS) works in promoting smoking cessation and preventing relapse in current smokers. rTMS is a form of brain stimulation therapy that controls nerve cell activity, increases blood flow in the brain, and improves cognitive function.

NCT ID: NCT03691350 Recruiting - Cigarette Smoker Clinical Trials

Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs

Start date: September 17, 2018
Phase: Early Phase 1
Study type: Interventional

This trial studies biomarkers obtained by bronchoscopy (bronchoalveolar lavage and lung brushings) to determine the effect of smoking e-cigarettes on the lungs. Studying samples of lung cells from participants who smoke e-cigarettes may help doctors learn more about changes that occur in deoxyribonucleic acid and identify biomarkers related to cancer.

NCT ID: NCT03669120 Completed - Cigarette Smoker Clinical Trials

Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking

Start date: August 10, 2018
Phase: N/A
Study type: Interventional

This trial studies how well tailored smoking cessation intervention works in promoting sexual and gender minority smokers to quit smoking. A program that is specifically designed for the lesbian, gay, bisexual, and transgender community may affect these participants differently than a traditional approach.

NCT ID: NCT03668769 Withdrawn - Malignant Neoplasm Clinical Trials

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

Start date: March 27, 2017
Phase: N/A
Study type: Interventional

This trial studies how well a mobile smartphone application called Quitting Schedule works in helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a computer-based initiative that offered state of-the-art smoking cessation treatment and counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for non-patients to find information regarding smoking cessation advice and treatments. Quitting Schedule may help participants to quit smoking.

NCT ID: NCT03519451 Active, not recruiting - Depression Clinical Trials

Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment

Start date: April 25, 2018
Phase: N/A
Study type: Interventional

This trial studies how well smartphone mobile applications work in enhancing smoking cessation treatment in current smokers. Smartphone mobile applications may help current smokers quit smoking.

NCT ID: NCT02224391 Completed - Clinical trials for Current Every Day Smoker

Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking

Start date: January 20, 2016
Phase: N/A
Study type: Interventional

This randomized clinical trial studies how well a smartphone-delivered attentional bias modification training works in helping patients quit smoking. Smartphone-delivered attentional bias modification training may help patients quit smoking by reducing the attentional bias (the tendency of one's perception to be affected by their recurring thoughts) towards smoking cues that developed over time as a result of conditioning processes through which smoking cues become important.

NCT ID: NCT01967082 Completed - Cigarette Smoker Clinical Trials

APPSPIRE App in Preventing Students From Smoking

Start date: October 16, 2013
Phase: N/A
Study type: Interventional

This trial studies how well APPSPIRE, a smartphone app, works in preventing students from smoking. Technology-driven intervention programs, such as the APPSPIRE app, have the potential to increase access to health behavior treatments and therapies, such as tobacco cessation support, and provide effective prevention messaging.

NCT ID: NCT00948129 Completed - Cigarette Smoker Clinical Trials

Mobile Smoking Cessation Intervention in Enhancing Cancer Outreach in Low-Income Adult Smokers

Start date: August 10, 2009
Phase: N/A
Study type: Interventional

This trial studies how well a mobile smoking cessation intervention works in enhancing cancer outreach in low-income adult smokers. Mobile smoking cessation intervention may help smokers quit or cut back on smoking, and help increase the range of cancer prevention services provided to low-income adult smokers.

NCT ID: NCT00941395 Completed - Cigarette Smoker Clinical Trials

Enhanced Smoking Cessation for University Students

Start date: June 30, 2009
Phase: N/A
Study type: Interventional

This trial studies how well a new smoking cessation and prevention intervention works in enhancing smoking cessation for university students. The new intervention may be easier to use for students to quit smoke.